Pazopanib HCL intermediates manufacturer

Pazopanib HCL intermediates
Tel: +86-311-67591193 sales@dingminpharma.com
  • HOME
  • ABOUT US
  • PRODUCTS
  • NEWS
  • SERVICE
  • CONTACT US
    • News
    Your location: Home » News > Company news

    new workshop in proceed

    Our new workshop in proceed.

    Our main products:INC 280 HCL/Capmatinib CAS:1029712-80-8, Crizotinib CAS:877399-52-5;Dacomitinib(PF299804) CAS:1110813-31-4;Trametinib CAS:871700-17-3;Larotrectinib(LOXO-101) CAS:1223403-58-4,Nirapatib CAS:103819-60-4;Olaparib CAS:763113-22-0;AZD-9291/Osimertinib CAS:1421373-65-0;

    Other Article
    Previous: The competition of oseltamivir is fierce, and the demand of API is rising
    Next: Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd
    PRODUCTS LIST
  • Anti-cancer
  • Muscle Relaxant
  • Antiviral
  • Hypoglycemic
  • Antihypertensive
  • Anticoagulant
  • Antifungal
  • Others
  • API
  • Agrochemicals
  • Herbal Extracts
  • Vitamins
  • Pestcide
    • CONTACT US
    Office Address: No.41, Zhaiying South Street, Yuhua District, Shijiazhuang, Hebei Province.China
    R&D and Plant Address: JingShi Cooperative Innovation Industrial Park,No.769 Taihang Street,High-tech Zone,Shijiazhuang
    Tel: +86-311-67591193
    Fax: +86-311-67591193
    sales@dingminpharma.com
    Copyright © 2015 Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd All rights reserved

    Online Service×
    +86-15933619867+86-18032440182